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Junctional epidermolysis bullosis OEB) is a heteroge­
neous inherited blistering disorder of human epithe­
lial basement membranes (BMs). Characteristically, 
the epidermis detaches from the BM between the basal 
cells and the lamina lucida due to reduced numbers of 
hemidesmosomes (HDs). Attempts to identify a candi­
date gene for JEB led to the characterization of nicein, 
a protein complex in normal BMs that is absent from 
BMs of patients with JEB gravis. In independent re­
search, two related BM glycoproteins, epiligrin and 
kaliDin, were identified as functional adhesion com­
ponents of HDs. Epiligrin was characterized as a BM 
ligand for basal cell adhesion via integrins a3p1 in 
focal adhesions and a6p4 in HDs. Kalinin was charac­
terized as an adhesive ligand and a component of 
anchoring filaments. Recent antibody and sequence 
JUNCTIONAL EPIDERMOLYSIS BULLOSIS: DEFECTS 
IN HEMIDESMOSOMES OF BASAL EPIDERMAL CELLS 
Junctional epidermolysis bullosis ijEB) is a blistering disorder of 
human epithelium and is inherited as an autosomal recessive muta­
tion(s) [1,2]. The clinical findings of blister formation with mild 
mechanical trauma to the epidermis occurs as a result of separation 
of viable basal cells from the lamina lucida of the basement mem­
brane (BM). At the ultrastructural level, the patients exhibit reduced 
numbers, or disorganization of hemidesmosomes (HDs) in the basal 
plasma membrane of the basal cells. Currently, there are seven var­
iant forms ofJEB recognized by the National Epidermolysis Bullosa 
Registry [1]. These variants range from the milder localized JEB 
inversa to the severe generalized JEB gravis/Herlitz form (formerly 
lethaljletalis). In this most severe form, HDs are usually severely 
reduced or absent in both lesional and unaffected areas of the epider­
mis. Together these results suggest that i) a genetic defect in an 
adhesion component(s} of HDs may be causal in JEB, and ii} that 
JEB is genetically heterogeneous with possible defects in more than 
one adhesion component. 
We identified a new BM glycoprotein, epiligrin, as the major 
component of the extracellular matrix (ECM) synthesized by cul­
tured human foreskin keratinocytes (HFK.s) [3]. Epiligrin is an ef­
fective ligand for adhesion of cultured keratinocytes and is a physio-
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PA, pyloric attesia. 
studies on epiligrinjnicein/kalinin have identified 
limited homologies with laminin. Ongoing studies in 
multiple laboratories seek to identify mutations in one 
or more of the three subunits of epiligrin that are 
causal in JEB gravis. Consistent with the genetic het­
erogeneity of JEB, we have identified a patient with a 
variant form of JEB that is associated with pyloric 
atresia. This patient has negligible HDs, normal epili­
grin, but reduced expression of integrin p4. A defect in 
the P4 expression may define a subset ofJEB cases that 
also present with pyloric atresia. These results testify to 
the dual requirements for epiligrin in the BM and inte­
grin P4 in the plasma membrane in regulating function 
of HDs in epithelium. Key words: epidermis/cell adhe­
sionjintegrinsjvesiculobulloNS skin diseases. J Invest Derma­
tol10J:J1S-JBS, 1994 
logically important mediator of basal cell adhesion to the BM. 
During the course of our studies on cell adhesion to epiligrin, it 
became apparent that epiligrin was related or identical to at least two 
other BM proteins [4], nicein [5,6] and kalinin [7]. Each of these 
three protein complexes had been identified independently; epili­
grin as an adhesive ligand for integrin adhesion receptors a3pl and 
a6p4 [3], kalinin as a component of the anchoring filaments asso­
ciated with HDs [7], and nicein/BM600/GB3 antigen, as a protein 
antigen that was absent from the BM of patients with the gravis 
form of JEB [5,6]. 
Knowledge of the structure/function of normal adhesion com­
ponents has led to an understanding of the molecular basis of inher­
ited and acquired blistering disorders of the epidermis. In the fol­
lowing two sections we will outline our current understanding of 
the molecular basis of normal cell-BM and cell-cell adhesion in the 
basal cell layer of the epidermis (see Fig 1 for a diagrammatic out­
line). Then we will evaluate candidate genes for JEB in relation to 
the components and mechanisms that mediate normal keratinocyte 
adhesion to the BM. 
CELL ADHESION IN BASAL CELLS OF THE EPIDERMIS 
Integrin and Cadherin Receptors in Anchoring Junctions 
Cell-cell and cell-substrate adhesion in the epidermis is mediated by 
two types of anchoring junctious termed i) adherens junctions in­
cluding focal adhesions (FAs) [8] and ii) HDs [9] and desmosomes 
[10]. Each anchoring junction consists of an extracellular ligand or 
co-receptor, a transmembrane adhesion receptor(s), and an asso­
ciated cytoskeletal complex. Desmosomes and HDs are stable an­
choringjunctions and mediate cell-cell and cell-BM adhesions, re-
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spectively. They are associated with intermediate filaments [11]. In 
contrast, adherens junctions are linked to actin containing-filaments 
[8] and are more dynamic and labile than desmosomes or HOs. 
Specialized forms of adherens junctions can mediate either cell-cell 
or cell-substrate adhesion. The integrin class of adhesion receptors 
are functional in FAs and HOs that mediate basal keratinocyte adhe­
sion to the BM. Cadherin adhesion receptors are present in cell-cell 
adherens junctions and desmosomes that mediate cell-cell adhesion 
in the epidermis [10]. 
Cell-Substrate Adhesion: Integrins in Hemidesmosomes and 
Focal Adhesions The integrins are the primary adhesion recep­
tors present in both FAs and HOs. Furthermore, FAs and HOs are 
the primary mediators of basal keratinocyte adhesion to the sub­
stratum. Integrins are heterodimeric adhesion receptors that contain 
dissimilar a and P subunits (for reviews see [12,13]). There are 
currently 13 different a subunits that associate with eight different 
p subunits. Normal human skin and cultured HFK.s express high 
levels of integrins a6p4, a3pl, and a2pl [14]. In addition, kerati­
nocytes in culture express detectable quantities of integrins alpl, 
a5pl, a6pl, avP5, and avP6, in part due to the activation-depen­
dent expression of these receptors in culture and in wounds [15,16]. 
Based on the described receptor-ligand interactions for many cell 
types the possible ligand-specificities for the major epidermal inte­
grin receptors are (for review see [17]) a2Pl, collagen [18] and 
laminin; a3Pl, epiligrin [3], fibronectin, collagen, entactin and la­
minin; a6p4, epiligrin [3], and laminin. However, studies with 
HFK.s indicate that the preferred ligand-specificities are a2pl, col­
lagen; a3pl, er.iligrin; and a6p4, epiligrin or an epiligrin associated 
component [3 . 
HOs are the primary cell-substrate adhesion structures identifi­
able in epidermis at the ultrastructural level, but are more difficult to 
detect in cell culture [14]. In skin, HOs are identified by electron 
microscopy as dense plaques localized to the cytoplasmic side of the 
basal membrane of keratinocytes attached to the BM. Immature 
forms of HOs have been identified in culture [11] and referred to as 
stable anchoring contacts (SACs) [14]. 
In the basal plasma membrane, HOs contain integrin a6p4 as a 
transmembrane adhesion receptor [14,17 -19]. In the cytoplasm, 
HOs contain a 230-kOa form of the bullous pemphigoid antigen 
(BPAG 1) as a component of the electron dense plaque [11]. BPAG 1 
is structurally and functionally related to desmoplakin I [11], a com­
ponent of the cytoplasmic plaque of desmosomes. BPAG2 is a 
unique transmembrane 180-kDa antigen that also localizes to HOs 
and contains an extracellular collagen-like sequence [20]. The cyto­
plasmic plaque of HOs also contains intermediate filaments [11], a 
newly identified 200-kOa component [21], and HO-l, a high mo­
lecular mass protein [22]. 
Basal cell adhesion to a substratum is mediated by F As in addition 
to HOs [3,23]. Keratinocytes in culture utilize Pl integrins in FAs as 
the primary adhesion receptor involved in recognition of extracel­
lular ligands [3]. In contrast to HOs, FAs are readily identified in cell 
culture but have not been identified in skin. The differences in 
detectability of HOs and FAs in tissue and culture may be due to 
differences in stability of the adhesion structures as well as function. 
FAs are relatively labile structures that are short-lived and may not 
be easily detected in normal epidermis. In contrast, HOs are stable 
structures [14]. Consistently, when anchored cells are induced to 
migrate, as in wound repair, a6p4 and BPAGl relocate from HOs 
to a diffuse distribution over the cell surface and cytoplasm [24]. 
The cytoplasmic tail of the integrin P4 subunit in HOs is larger 
(1000 amino acids) than that of the Pl integrin (50 amino acids) 
[19]. The unique cytoplasmic sequences of the P4 and Pl subunits 
regulate associations of the HOs and FAs with keratin and actin 
filaments, respectively, through their associated cytoplasmic linker 
proteins. 
Despite the instability of FAs relative to HOs, F As are formed in 
cultured cells only after initial adhesion, cell spreading, and migra­
tion have ceased. Adhesion structures that mediate initial adhesion, 
spreading, and migration are not detectable by light microscopy and 
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are not well-characterized. However, they are probably structurally 
and functionally similar to FAs. This suggested similarity is based on 
the fact that anti-integrin antibodies that block or activate initial cell 
adhesion, spreading, and migration react with the same integrin 
receptors that localize in FAs [25]. Although the labile adhesion 
structures that mediate migration contain integrins and actin fila­
ments, a cascade of regulatory factors and cytoskeletal linker pro­
teins may modulate the function of the integrins and actin filaments 
and may distinguish migration adhesion structures from FAs. The 
role of integrins and actin-containing filaments and associated cyto­
skeletal components in regulating locomotion has recently been 
reviewed [26]' Vesicular traffic may provide adhesion receptors in 
tips oflamella of migrating cells that are subsequently incorporated 
into adhesion structures and are eventually endocytosed behind the 
leading edge of the cell. 
In FAs, the Pl or P3 subunit of the integrin heterodimer receptors 
are associated directly with cytoplasmic talin or a-actinin and indi­
rectly with vinculin, paxillin, zyxin, tensin, and a series of regula­
tory components including the tyrosine kinases, pp60src, and 
p125PAK [27]. For example, overexpression of vinculin suppresses 
cell motility [28]. Phosphorylation of tyrosine residues in tensin, 
zyxin, paxillin, and p125PAK has been implicated as a regulatory 
signal for assembly/disassembly ofFAs [27]. 
Cadherin adhesion receptors are involved in cell-cell adhesion of 
basal cells but are not directly involved in basal cell adhesion to the 
BM and will only be discussed briefly. Cadherins are Ca++-depen­
dent mediators of homotypic cell-cell adhesion and are the primary 
cell-cell adhesion receptors in the epidermis [29]. There are two 
major classes of cadherins termed classical cadherins and desmoso­
mal cadherins that are components of adherens junctions and des­
mosomes, respectively [9,29]. The two types of cadherins exhibit a 
high degree of sequence homology in their extracellular domains 
but differ in their cytoplasmic sequences that associate with the 
cytoskeleton. Epidermal cells express cell-cell adherens junctions 
that contain classic cadherins that associate with actin filaments. P 
cadherin is expressed primarily in the basal cell layer whereas E 
cadherin is expressed in basal, suprabasal, and spinous cells [30]. 
Epidermal cells also form extensive cell-cell adhesions of the 
desmosomal type [9] that facilitate the epidermal function as a per­
meability barrier. Oesmoglein [31] and desmocollins [32] are adhe­
sion components of the desmosomes and are referred to as desmoso­
mal cadherins [9,29]. Oesmosomes are relatively few in the basal 
cell layer but are upregulated in the suprabasal and spinous cell layer. 
Consistently, serum from patients with the autoimmune blistering 
K-Iaminin Kalinin 
Am Am 
Figure 1. Schematic lllustratioD of laminin variants. The isofonru 
Ae-Ble-B2e, Ae-Bls-B2e, Am-Ble-B2e, and Am-Bls-B2e have been iso­
lated from several tissues. The exact nature of the kalinin (epiligrin/nicein) 
and K-laminin isoforms remains to be established, as the tentatively geneti­
cally distinct truncated At and B 1 t chains have not yet been completely 
sequenced. Reprinted from [40]. 
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Figure 2. Overview: sequential roles for integrins al/l1 and a6/14 in adhesion of epidermal basal cells to epiligrin in the BM. Our current 
understanding of the sequential expression and function of integrins cr.3Pl and cr.6P4 adhesion structures is summarized diagrammatically for basal and 
suprabasal cells layers of the epidermis. Basal layer: basal keratinocytes synthesize, attach, and spread on epiligrin in the BM via cr.3Pl that associates with actin 
containing stress fibers. In culture, progressive changes in adhesion structures correlate with decreasing migration, increased cell-cell contact, and increased 
stability of the cell-substrate adhesions. Initial attachment, spreading, and migration (see Migration) precede formation of cr.3Pl in FAs (Attachment). The 
formation of cr.3PI-FAs functions as a nucleation site for the reorganization of cr.6P4 into stable HDs (Anchorage). Concurrent with the formation of the HDs, 
cr.3Pl is upregulated in cell-cell contacts and functions in cell-cell adhesion with cr.2Pl as a co-receptor as previously described [44]. We suggest that regulation 
of adhesion to epiligrin in the BM via cr.3Pl and cr.6P4 plays a major role in regulation of differentiation and activation in wound repair. Epiligrin expression is 
upregulated (i) in migrating and proliferating cells at the edge of wounds or colonies in culture or tissue [46]. Conversely, increased cell density results in 
decreased synthesis of epiligrin m, increased formation of stable cr.3PI-FAs followed by increased cr.6P4-HDs, and cr.3Pl and cr.2Pl at cell-cell contacts. 
Suprabasal layer: In culture, detachment (Detachment) of basal cells from the BM with inhibitory antibodies to cr.3Pl induces cr.3pl-mediated cell-cell adhesion 
[44] and expression of involucrin,t a component of the granular cell layer (Differentiation). This suggests that cell adhesion to epiligrin inhibits epidermal 
differentiation whereas detachment induces cr.3Pl function in cell-cell adhesion as a normal differentiation step. Detachment of basal cells results in 
downregulation of integrins and epiligrin. 
disorder, pemphigus vulgaris (PV), express autoantibodies that 
cause detachment of suprabasal cells from the basal cells. Recently 
the PV antigen was shown to be identical to desmoglein, a desmo­
somal cadherin [33]. The PV antigen, like the desmosome, is upreg­
ulated in the suprabasal cell layer where it is a target for the autoim­
mune antibodies. 
The Basement Membrane Gipson et al [34] suggested that for­
mation of HDs by basal cells may be controlled by the components 
of the BM. The unique organization of the epidermal BM in prox­
imity to HDs supports its possible regulatory role in HD formation 
[35]. The synthesis and assembly of the BM is a cooperative effort of 
epidermal and dermal cells. In the epidermal BM, type VII colla­
gen-containing anchoring fibrils in the dermis extend into the lam­
ina densa of the BM adjacent to HDs [36] . Anchoring filaments 
extend from the anchoring fibrils across the lamina lucida, to the 
HDs. These BM structures may function as nucleation points for 
formation of FAs and HDs via integrin adhesion receptors. The 
composition of the anchoring filaments is being established and 
may include a number of related glycoproteins; epiligrin [3], kalinin 
[7], a 125-kDa BM component [37], and the high-molecular-mass 
antigen complex recognized by the GB3 monoclonal antibody 
(MoAb), termed nicein [5]. Recently epiligrin [4] and kalinin [38] 
were shown to be related to nicein. It is likely that epiligrin/ka­
linin/nicein are related to a unique truncated laminin chain, termed 
B2t, that was recently cloned and sequenced [39] . 
Multiple variant forms of laminin are present in the lamina lucida 
of the epidermal BM [39-42] and include epiligrin, K-Iaminin 
described by the Burgeson lab [42]. and EE laminin that may be 
related to K-Iaminin (see later discussion). A recent review by 
Tryggvason [40] has described the known and putative subunit 
compositions of the laminin variants and is summarized in Fig 1. 
K-laminin is a laminin isoform that is co-purified with kalinin and 
may be immunologically related to kalinin. K-Iaminin contains la-
minin Bie and B2e subunits and a third alternate A chain or At 
subunit [40] that is immunologically related to the BM165 chain of 
kalinin [42] . Additional components of the BM include entactin/ 
nidogen. heparan sulfate proteoglycan. and type IV collagen [35] . 
Epiligrin ([3] and see later discussions). laminin variants. collagen. 
and entactin/ nidogen have all been shown to interact with integrins 
in vitro and may contribute to basal cell adhesion to the BM in vivo 
(for review see [17]). This suggests that basal cell adhesion to the 
BM may involve one or more different receptors. ligands and an­
choring junctions. 
EPILIGRIN. AN EPIDERMAL BASEMENT MEMBRANE 
LIGAND FOR INTEGRINS a3p1 AND a6p4 
Differential and Polarized Expression of Integrins In nor­
mal skin. expression of the major integrins. a6p4. a3pi. and a2pl. 
is restricted to the proliferating basal/suprabasal cell layers. An out­
line for the possible unique functions for the different integrins is 
presented diagrammatically in Fig 2. The distribution of the inte­
grins in normal epidermis and epidermis from donors with JEB is 
presented in Fig 3. All three integrins are down-regulated in the 
differentiated spinous cells [15.16.43]. For example. during suspen­
sion-induced terminal differentiation of keratinocytes. the aSp1 
integrin is also down-regulated and this occurs in two stages. First. 
the ability of the receptor to bind fibronectin declines. Second. 
mRNA levels reduce and the quantity of receptor declines. The 
decline reflects both inhibition of subunit transcription and inhibi­
tion of maturation and intracellular transport of subunits [15]. Ex­
pression of a6p4 is restricted to the basal plasma membrane ([3.17] 
for review) except in developing epidermis prior to formation of 
HDs. In contrast. a3p1 is expressed on the basal. lateral. and apical 
t Symington BE. Carter WG: Modulation of epidermal differentiation by 
epiligrin and integrin cr.3Pl (manuscript submitted). 
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Figure 3. Imm_operoxiclase Staining of Cryostat Sections of SkiD From a Healthy Neonate, a JEB Gravis Patient aDd a JEB Patient With 
Pyloric: Atresia (JEB/pA). Skin sections from a healthy neonate (panels A,D,GJ) a JEB gravis patient (B,E,H,K) and a JEB/PA patient (e,F,I,L) with 
indicated MoAb for a3pl (A -C), epiligrin (D-F), p4 subunit (G-I), and a6 subunit a -L). Sections from the two individuals with JEB display both areas of 
epidermal/dermal attachment and detachment with small blisters (b). The patient with JEB and JEB/P A exhibited no detectable HDs by electron microscopy. 
The basement membrane region associated with the dermal side is detnarcated by arrows, The individual with JEB gravis alone exhibits an absence of epiligrin 
(E), which has previously been associated with the JEB gravis (or Herlitz) subgroup. In contrast, the fetus diagnosed with JEB/PA has nonnal epiligrin 
expression (F), but an absence of detectable P4 subunit (1) and reduced a6 subunit (L) expression at the basal surface of the basal epidermal cells. 
membranes whereas oap1 is expressed primarily on the apical and 
lateral membranes [44]. This suggests that a3p1 functions in both 
cell-cell and cell-BM adhesion in normal epidermis. a3p1 has been 
shown to mediate cell-cell adhesion as well as cell substrate adhesion 
to epiligrin 13.23,44). 
EpiligriD, A LigaDd for Cell AdhesioD to the BM Epiligrin is 
an effective ligand for adhesion of keratinocytes and other cells to 
the substratum via integrin a3p1 [3.44,45]. In addition. epiligrin 
co-distributes with integrin a6p4 in HD-like SACs [3]. suggesting 
that it may function as a ligand for a6p4. In culture. a6p4 forms a 
stable complex with exogenous HFK-ECM [3.14] indicating that 
exogenous epiligrin controls the organization of endogenous a6p4. 
Further. JEB and epiligrin cicatricial pemphigoid. an acquired au­
toimmune blistering disorder. appear to be due to disorders of epili­
grin ([4] and see later discussion). Together these results indicate 
that epiligrin interacts directly with a3pl and directly or indirectly 
with a6p4 in HDs. and these interactions are instrumental in basal 
cell attachment to the BM. Recently. we have shown that disrup­
tion of basal cell interactions with epiligrin with anti-a3p1 MoAb 
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Table I. Characteristics of New Anti-Epiligrin Monoclonal Antibodies 
Reaction of the Antibody with 
Antibody HFK-ECM" 
Epiligrin/EE-Laminin Specific 
PtEl + 
G3-3-SG + 
03-4-SG + 
P3H9-2-EW + 
Epiligrin-Specific 
P3ClO-A6 + 
C2-9-SG + 
B4-6-SG + 
P3E4-EW + 
GB3 + 
Tissue' 
Normal 
Epi End Epi 
+ ± 
+ + + 
+ + + 
+ + + ... 
+ 
+ 
+ 
+ 
+ 
JEB Epiligrin' 
End Blot Rip 
± + 
+ + 
+ + 
+ + 
+ + 
+ 
+ + 
+ 
+ 
EE-LAMd 
Rip 
+ 
+ 
+ 
+ 
Attachment Inhibition' 
Epi 
± 
+ 
++ 
Col Fn 
• Immunofluorescence microscopy of ECM from cultured HFKs. 
6Immunoperoxidase staining of nonnal and JEB gravis skin (sample: SA 8-14-92); epidennal (Epi) and endothelial (End) BM. 
• Immunoblot (Blot) or immunoprecipitation (Rip) reaction with epiligtin after aJlinity purilication from HFK culture supernatant. 
� None of the antibodies react with human placental laminin. However, epiligrin/BE-laminin antibodies co-precipitate a laminin-like protein of 190/230, referred to as 
EE-Laminin (BE-LAM). 
• MoAb C2-9-SG >P3H9-2-EW > D3-4-SG inhibit cell adhesion to epiligrin (Epi) but not collagen (Col) or Fibronectin (Fn). 
induces expression of involucrin,:j: a late-stage differentiation com­
ponent involved in formation of the cell envelope (Fig 2). This 
suggests that interactions of the basal cells with epiligrin via a3pl 
and possibly a6p4 may play a role in regulating proliferation, dif­
ferentiation, and stratification in the epidermis. 
Epiligrin contains three disulfide-bonded, non-collagenous, gly­
coprotein subunits, E170, E 145, and E135, based on molecular mass 
in kDas [3]. Two additional glycoproteins, E200 and EI00, are 
variably associated with epiligrin and are a precursor to E 170 and a 
degradation product of the E145 subunit, respectively. We prepared 
MoAb PIE 1 that reacts with E170, and was used for the initial 
immunopurification of epiligrin from HFK culture medium and for 
localization studies. Immunolocalization in tissue identified epili­
grin in the dermal-epidermal junction of epithelial cells in organs 
primarily of endodermal/ectodermal origin. At the ultrastructural 
level, epiligrin localized to the lamina lucida of BMs. 
We compared cell adhesion to epiligrin via integrin a3pl in focal 
adhesions (FAs) with a6p4 in hemidesmosomes (HDs) as mediators 
of distinct epithelial cell adhesion and signaling functions.§ a3-
transfected K562 cells, fibroblasts, HTI080 fibrosarcoma cells, and 
melanocytes attach and spread on epiligrin via a3pl. Both attach­
ment and motility on epiligrin are blocked with monoclonal anti­
bodies (MoAbs) againsta3 (PIB5),Pl (P4CI0), epiligrin (C2-9), or 
at 4· C, whereas attachment and motility of human foreskin kerati­
nocytes (HFKs) on epiligrin involves both a3pl and a6p4. Anti-a3 
MoAb blocks cell spreading but not attachment. In contrast, anti-a6 
(GOH3) was unable to block either attachment or spreading but 
inhibited HD formation as evidenced by inhibition of localization 
of bullous pemphigoid antigen I (BP AI) in HDs. When anti-cd and 
anti-a6 were combined they blocked both attachment and spread­
ing of HFKs on epiligrin [14]. We then evaluated HFK adhesion to 
epiligrin via a6p4 at 4· C, a condition that inhibits a3pl-dependent 
adhesion. Attachment of HFKs at 4· C occurs without spreading 
and is blocked with anti-a6 MoAb indicating that a6p4 mediates 
attachment independent of a3pl. Both attachment of HFKs via 
a6p4 and spreading via a2pl are blocked with anti-epiligrin MoAb 
(C2-9) confirming the dual roles of epiligrin in adhesion via both 
receptors. Anchorage ofHFKs to epiligrin via a6p4 is distinct from 
adhesion and spreading on epiligrin, fibronectin, or collagen via PI 
integrins because i) it is more rapid than adhesion via PI integrins 
§ Gil SG, Xia Y, Takada Y, Carter WG: Functions for integrins a6p4 in 
anchorage and a3pl in motility of keratinocytes on epiligrin (manuscript 
submitted). 
and occurs at 4· C; ii) it does not result in cell spreading. Thus, 
epithelial cells, in contrast to many other cells that express only 
a3p1, control motility and stable anchorage on epiligrin by differ­
ential use of a3pl and a6p4 in HDs, respectively, resulting in 
distinct transmembrane signals. 
Identification of EE-Iaminin and Its Relation to Epiligrin 
Immunoprecipitation of the epiligrin heterotrimer E170 (putative 
laminin At subunit), E145/EI00 (laminin B2t), and E135 (putative 
laminin BIt) from conditioned culture medium of HFKs with 
MoAb PIE1 also precipitated proteins of 230 and 190 kDa [3]. The 
230/190 protein was described as laminin-like because it could be 
removed by precipitation with anti-Iaminin antibodies that did not 
precipitate epiligrin . Thus, epiligrin was defined as the heterotrimer 
(E170, EI45/EI00, E135) that was immunoprecipitated withPIEI 
after preclearing with anti-Iaminin antibodies [3]. We suggested 
that the laminin-like complex is either bound to epiligrin and/or 
cross reacts with the P1E1 MoAb . For simplicity in the following 
discussion we will refer to the 230/190 laminin-like complex as 
EE-laminin because it is expressed in BM of both epidermis (E) and 
microvascular endothelium (E). Conceivably, EE-Iaminin may be 
related to K-Iaminin described by Marinkovich et al [42]. However, 
neither antibody nor eDNA probes specific for K-laminin or EE-Ia­
minin are currently available to evaluate their relationship at this 
time. 
We have identified seven new MoAb that react with epiligrin 
[45]. These MoAb have been categorized as specific for epiligrin or 
epiligrin/EE-Iaminin based on differences in results from immuno­
precipitation and tissue staining. The characteristics of these MoAb 
are summarized in Table I and Fig 4 and as follows: i) all seven 
MoAb react with epiligrin as determined by preclearing with anti­
epiligrin P1El MoAb; ii) three of the MoAb inhibit melanocyte, 
keratinocyte, T-cell, and fibroblast adhesion to epiligrin but not 
collagen, laminin, or fibronectin; iii) epiligrin/EE-Iaminin­
specific MoAb, including the original PIE1 MoAb, precipitate both 
the 190/230 kDa EE-Iaminin and the three subunits of epiligrin 
(E170, EI45/£100, E135); iv) epiligrin-specific MoAb precipitate 
epiligrin but not EE-Iaminin; v) in skin, epiligrin-specific MoAb 
stain only epidermal BM whereas epiligrin/EE-Iaminin-specific 
MoAb stain epidermal and endothelial BM in the microvasculature 
(Fig 4). 
These results indicate that EE-Iaminin is present in BMs of the 
epidermis and microvascular endothelium whereas epiligrin is ex­
pressed only in epidermal BMs. These results also indicate that 
epiligrin and EE-Iaminin share multiple common epitopes recog-
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Figure 4. ImmllDOStainiDg of Cryostat Sections of Skin From a Nor­
mal DODor. aDd a PatieDt withJEB Gravis With MoAb Specific For 
Epiligrin aDd Epiligrin/EE-LamiDiD. Immunoperoxidase staining of 
cryostat sections of skin from a healthy neonate (A,B) and a JEB gravis 
patient (C,D; individual SA 8-14-92 in Table D) with either MoAb 03-4 
recognizing both epiligrin and EE-laminin (A,C) or the epiligrin-specific 
MoAb B4-6 fB,D). Sections from the individual with JEB gravis display 
both areas 0 epidermal/dermal attachment and detachment with small 
blisters (b). Arrows indicate either the location of the microvasculature in the 
dermis of normal neonatal skin (A,B) or the location of the epidermal 
basement membrane inJEB gravis skin (C,D). In the healthy control, the 
B4-6 staining is restricted to the epidermal basement membrane (B), 
whereas 03-4 also detects the basement membrane in the microvasculature 
(A). In the JEB gravis patient, some staining with 03-4 (C), but not B4-6 
(D), is noticeable in the basement membrane region. 
nized by a number of MoAb. Thus, the E170 subunit of epiligrin 
and at least one subunit ofEE-laminin are immunologically related. 
EE-Iaminin and epiligrin can be immunoprecipitated indepen­
dently, indicating that they are not covalently associated in the 
conditioned tissue culture media (Gil and Carter, manuscript in 
preparation). 
We have identified and sequenced multiple eDNA clones encod­
ing the 170-kDa subunit of epiligrin [46]. Consistent with the im­
munologic data above, partial sequence analysis of the eDNA clones 
for E170 revealed a homology with domains IlIa and II of human 
laminin A chain. Domain lIla encodes a cysteine-rich region con­
taining multiple EGF-like repeats [41]. Sequence alignment of 
E170 and human laminin A chain in domain lIla showed conserva­
tion of the cysteine residues and 55% sequence homology. In con­
trast to domain III, the primary amino acid sequence in domain II is 
A 
9.5 
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tubulin 
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Figure S. Northern Blot Analysis of Total Cellular RNA Isolated 
From HamaD Foreskin KeratiDocytes and Fibroblasts aDd Northern 
Blot Analysis of RNA Isolated From Proliferating and DiffereDtiat • 
iDgKeratiDocytes.A) Keratinocytes (lane 1), FEP18-11 (lane 2), FEPIL-8 
(land), and human foreskin fibroblasts (lane 4). FEPI8-1l and FEP1L-8 are 
human foreskin keratinocytes that have been transformed with human pa­
pilloma virus. Hybridization with an epiligrin-specific cDNA probe detects 
two transcripts, approximately 5 and 6 kb in size, which are significantly 
decreased in the cell lines that have been transformed with papilloma virus 
(lanes 2,3). No signal is detectable in human foreskin fibroblast RNA (lane 4) 
that was included as a negative control. Positive hybridization to tubulin 
mRNA shows that equal amounts of RNA were loaded in lanes 1-4. B, 
Proliferating keratinocytes (lane 1), keratinocytes treated with 1.3 mM of 
Ca++, (lane 2), and confluent keratinocytes (lane 3). The reduced signal in 
lanes 2,3 show that the epiligrin transcript is significantly decreased by 
factors that cause keratinocyte differentiation. Photograph of 28S and l8S 
RNA shows that equal amounts of RNA were loaded in lanes 1-3. 
less well-conserved between E 170 and laminin A chain. However, a 
structural relationship is maintained in that both proteins encode 
alpha-helical domains characteristic of a coiled-coil structure previ­
ously described for laminin [41]. Complete sequence analysis will be 
necessary to determine how E170 relates to the other domains 
present in laminin. 
Regulation ofEpiligrin Expression: EfFects of Cell Density. 
Wounding, and Oncogenic Transformation Northern blot 
analysis of HFK mRNA with a eDNA probe (Fig SA; Ep-1 tran­
script) specific for epiligrin identified at least two mRNAs of5 and 6 
kb. These sizes are compatible with the expected mRNAs coding 
for the E170 subunit of epiligrin. It is possible that the two mRNA 
transcripts correspond to the E170 subunit of epiligrin and the im­
munologically-related subunit ofEE-laminin. Northern blot analy­
sis of HFK mRNA and mRNA from HPV transfonned HFKs 
. (FEPEIL-8 cells) identified reduced amounts of epiiigrin mRNA in 
the FEPE 1L-8 cells. This confirms and extends our published report 
that transformation by HPV causes decreased expression of HFK 
ECM [47]. 
In human wounds, we have observed that epiligrin is deposited in 
BM localized to the leading edge of the migratory tongue of epithe­
lium 24, 48, and 72 h after wounding in normal human volunteers 
[46]. In these wounds, epiligrin and a3p1 were polarized to the 
basal surface of cells in the migrating epithelial tongue. In situ hy­
bridization with anti-sense cRNA probes specific for epiligrin iden­
tified elevated epiligrin mRNA in the wound site. These data sug­
gest that a3p1 and epiligrin may be of primary utility during 
epidermal migration and wound repair, possibly in relation to the 
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Table II. Screening Results for Skin Samples from Patients with Epidermolysis Bullosaa 
Antigen 
Clinical Classification (Patient) Biopsy Source a3pl ( P I F2)  a6p4 (3E l )  Epiligrin (P I E l )  
-------------------------------------------------------------------------------------------
Normal 
Fetal epidermis 
Neonatal Foreskin 
Adult 
Junctional 
Mitis 
EB86-2A (sib) 
EB86-2 (sib) 
Gravis 
PNDX9 1-4 
YS 8-1 4-92 
With Pyloric Atresia 
EB92- 1 1  
Simplex 
S 7-1-91  
(+ muscular dystrophy) 
EB9 1-9 
Dystrophic 
EB9 1 -4 
Sybert/Smith 
Sybert/Smith 
Folk/Holbrook 
Yordy/Sybert 
Dolan/Sybert 
Sybert 
Sybert/Smith 
Sybert/Smith 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0 
0 
+ 
+ 
(a6+p4- ) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
• -, not detectable by immune peroxidase staining of crystat sections; 0, expression with altered organization. 
deposition and assembly of epiligrin in the BM. In contrast, laminin 
and a6p4 were reduced in cells at the leading edge of the migratory 
epidermal tongue, consistent with the role of HDs as stable adhe­
sion structures for non-migrating cells [24) . In related results, 
northern blot analysis of mRNA from HFKs grown at low density 
versus confluence identified a dramatic increase in expression of 
epiligrin mRNA in sparse cells (Fig SB) .  This indicates that epili­
grin mRNA is upregulated at low cell densities as occurs at the 
wound edge. Together, these results indicate that expression of 
epiligrin is upregulated by wounding or reduced cell-cell contact 
and downregulated by detachment from the substratum. It should 
be noted that the decreased expression of epiligrin in transformed 
cells contrasts markedly with the observed increase in epiligrin in 
wounds. Thus, the migration of wound cells may be self-limiting by 
the production of a restricting BM. In contrast, the migration of 
transformed cells in a wound environment would have no such 
limitation. 
Overall ,  epiligrin expression at the mRNA levels is relatively low 
in normal homeostatic epidermis. Wounding, tissue culture, 
TGFo:, and TGFp each upregulate epiligrin expression. In contrast, 
detachment induced differentiation or immortalization with E6 and 
E7 genes from HPV downregulate expression of epiligrin [46) . 
REDUCED EXPRESSION OF EPILIGRIN AND 
INTEGRIN P4 IN JUNCTIONAL EPIDERMOLYSIS 
BULLOSIS 
We have identified both acquired [4) and inherited epidermal blis­
tering disorders that may be caused by defects in the adhesive func­
tion and/or expression of epiligrin and the P4 integrin subunit. 
Results from these studies support the proposed functions for epili­
grin andp4 as physiologically significant components ofHDs and as 
mediators of basal cell adhesion to the BM in vivo. 
Epiligrin is related to nice in [4) , a BM protein that is decreased or 
absent in BM of patients with the gravis form ofJEB. Consistently, 
we have observed decreased expression of eEiligrin as detected with 
MoAb P1El  in patients with JEB gravis (Fig 3), but not milder 
localized forms of JEB, simplex, or dystrophic EB, as previously 
reported [3). The results from these studies are summarized in 
Table II and are consistent with published results for nicein [6) . 
Cultured keratinocytes from one of the JEB gravis patients were 
weakly attached and did not spread when compared to cultured 
keratinocytes from normal donors. Consistent with the absence of 
epiligrin in the BM, the patients' cells failed to deposit epiligrin into 
the ECM as detected by immunofluorescence microscopy with 
anti-epiligrin MoAb (Brown et aI, manuscript submitted) . 
Immunostaining of the JEB skin samples with MoAb specific for 
epiligrin or epiligrin/EE-Iaminin confirmed the results in both 
Table I and Table II. Epiligrin was found to be completely absent 
from both the BM of patients with JEB gravis and BM of microvas­
culature when detected with MoAb specific for epiligrin (Fig 4). In 
contrast, MoAb specific for epiligrin/EE-Iaminin were reduced in 
the epidermal BM but still clearly detectable, suggesting the contin­
ued expression of EE-Iaminin in the epidermal BM (Fig 4). Re­
cently, two JEB patients with mutations in the LAMB2T gene were 
identified a. Uitto and K. Tryggvason, personal communication) . 
One of their patients had a homozygous splice site mutation in the 
LAMB2T gene that resulted in deletion of exon 9. A second patient 
had a heterozygous deletion-insertion mutation in the LAMB2T 
gene that resulted in premature termination. This data suggests that 
mutations in the LAMB2T gene may be causal in some forms of 
JEB. 
We also examined skin samples from a fetus diagnosed with JEB 
gravis, combined with pyloric atresia (PA) , or incomplete formation 
of the pyloris. Ultrastructural analysis of the epidermis from this 
patient detected severely reduced numbers ofHDs at the epidermal 
junction with the BM [48) , consistent with the clinical diagnosis of 
JEB gravis.  Surprisingly, skin samples from this patient expressed 
normal levels of epiligrin (Fig 3, JEB/PA) . Consistent with this 
result, four different cases of combined JEB with P A have been 
reported to be positive for nicein/ epiligrin [49 - 52) .  This clinical 
phenotype may define a pleiotropic effect of a single gene or defects 
in two closely l inked genes. Further analysis of this skin sample 
identified normal 0:3 and 0:6 expression but absence of detectable P4 
(Fig 3 ,  JEB/PA; Brown et aI, manuscript in preparation) . This phe­
notype of P4-, epiligrin+, may define a new variant of JEB that is 
distinct from JEB gravis which is epiligrin-, p4+. Further, these 
results testify to the physiologic significance of P4 in formation of 
HDs. Defects in either epiligrin or P4 result in reduced HD forma­
tion and epidermal blistering at the lamina lucida. 
In situ hybridization of skin sections from the JEB/PA patient 
with P4 cRN A probes suggests that mRN A specific for P4 continues 
to be expressed in basal epidermal cells although P4 protein is not 
detectable (Brown et aI, work in progress) . This suggests that the P4 
mRNA encodes a mutation that results in decreased synthesis, in-
38S GIL ET AL 
creased turnover, or failure of P4 protein to incorporate into the 
HDs. 
JEB is a genetically heterogeneous blistering disorder with possi­
ble inherited mutations in epiligrin and integrin p4. These defects 
result in inadequate expression of epiligrin and P4, incomplete as­
sembly ofHDs resulting in blister formation. These results testify to 
the physiologic significance of epiligrin and P4 in HD formation. 
Additional information about i) the molecular characteristic of the 
inherited mutations, ii) the effects of these adhesion defects on the 
development biology of the affected tissues, and iii) the role of other 
components, such as K-Iaminin, EE-larninin, and BPAG2, in the 
function ofHDs are interesting areas for future studies. These stud­
ies may provide clinical approaches for treatment of the pathologic 
effects of this form of blistering disease. 
This work was supported by grants from the National Institutes of Health, R01-
CA49259 (WGC), P01-AR21557 (WGC), and F32-GM15085 (MCR), 
and the American Cancer Society, CB-59I (WGC). 
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